as 04-18-2025 1:41pm EST
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | NEW YORK |
Market Cap: | N/A | IPO Year: | 2017 |
Target Price: | $3.03 | AVG Volume (30 days): | 459.9K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.37 | EPS Growth: | N/A |
52 Week Low/High: | $0.24 - $3.45 | Next Earning Date: | 05-13-2025 |
Revenue: | $566,000 | Revenue Growth: | 44.39% |
Revenue Growth (this year): | -51.34% | Revenue Growth (next year): | 36.11% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Rona Jeffrey A | OVID | CBFO | Feb 26 '25 | Sell | $0.56 | 3,902 | $2,185.12 | 67,973 | |
ALEXANDER MARGARET A. | OVID | President and COO | Feb 26 '25 | Sell | $0.56 | 5,279 | $2,956.24 | 73,406 | |
ALEXANDER MARGARET A. | OVID | President and COO | Jan 27 '25 | Buy | $0.73 | 6,810 | $4,971.30 | 34,935 |
OVID Breaking Stock News: Dive into OVID Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Simply Wall St.
a month ago
MT Newswires
a month ago
Zacks
a month ago
GlobeNewswire
a month ago
Simply Wall St.
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
The information presented on this page, "OVID Ovid Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.